Molecular Devices Announces Webcast of Presentation Thomas Weisel Partners Healthcare Tailwinds Conference

Apr 02, 2001, 01:00 ET from Molecular Devices Corp.

    SUNNYVALE, Calif., April 2 /PRNewswire/ --
 Molecular Devices Corporation (Nasdaq:   MDCC) announced today that its
 presentation at the Thomas Weisel Partners Healthcare Conference in San
 Francisco, California, will be webcast live on Tuesday, April 3, 2001, at
 12:30 p.m. (Pacific Time). Senior Management of Molecular Devices will be
 presenting an overview of the company.
     Interested investors can access the live webcast at:
 
     http://www.veracast.com/twp_healthcare_2001/webcasts/37208178.cfm
 
     A replay of the presentation will be available by the end of the day and
 will be archived for 30 days.
     Molecular Devices Corporation is a leading developer of high-performance,
 bioanalytical measurement systems that accelerate and improve drug discovery
 and other life sciences research. Molecular Devices' systems enable
 pharmaceutical and biotechnology companies to leverage advances in genomics
 and combinatorial chemistry by facilitating the high throughput and cost
 effective identification and evaluation of drug candidates. Molecular Devices'
 instrument systems are based on its advanced core technologies which integrate
 its expertise in engineering, molecular and cell biology and chemistry and are
 fundamental tools for drug discovery and life sciences research.
 
 

SOURCE Molecular Devices Corp.
    SUNNYVALE, Calif., April 2 /PRNewswire/ --
 Molecular Devices Corporation (Nasdaq:   MDCC) announced today that its
 presentation at the Thomas Weisel Partners Healthcare Conference in San
 Francisco, California, will be webcast live on Tuesday, April 3, 2001, at
 12:30 p.m. (Pacific Time). Senior Management of Molecular Devices will be
 presenting an overview of the company.
     Interested investors can access the live webcast at:
 
     http://www.veracast.com/twp_healthcare_2001/webcasts/37208178.cfm
 
     A replay of the presentation will be available by the end of the day and
 will be archived for 30 days.
     Molecular Devices Corporation is a leading developer of high-performance,
 bioanalytical measurement systems that accelerate and improve drug discovery
 and other life sciences research. Molecular Devices' systems enable
 pharmaceutical and biotechnology companies to leverage advances in genomics
 and combinatorial chemistry by facilitating the high throughput and cost
 effective identification and evaluation of drug candidates. Molecular Devices'
 instrument systems are based on its advanced core technologies which integrate
 its expertise in engineering, molecular and cell biology and chemistry and are
 fundamental tools for drug discovery and life sciences research.
 
 SOURCE  Molecular Devices Corp.